53. Клигуненко е.Н., Дзяк л.А., Площенко ю.А., Емельянова е.А., Зозуля о.А. Нейропротекция в анестезиологии и интенсивной терапии // Международный неврологический журнал, 2008, 2 (18).

54. Chen H., Chopp M., Chultz L. et al. J Neurol Sci 1993; 118: 106 – 109.

55. Clark R.K., Lee E.V., Fish C.J. et al. Brain Res Bull 1993; 31: 565 – 572.

56. Graeber M.D., Streit W.J. Brain Pathol 1990; 1: 2 – 5.

57. Wood P.L. Life Sci 1994; 55(9): 666 – 668.

58. Giulian D. Reactive microglia and ischemic injury. In: Primer on Cerebrovascular Dis eases (Welsh M., Caplan L., Siesjo В., Weir B. Reis D.J. eds.). San Diego, CA, Academic 1997; 117 – 124.

59. Banati R.B., Gehrmann S., Schubert P., Kreutzberg G.W. Glia 1993; 7: 111 – 118.

60. McGeer E.G., McGeer P.L. Neurodegeneration and the immune system. In: Neurodegenerative Diseases (Calne D.B. ed.). Philadelphia, Saunders, Harcourt, Brace & World 1994; 277 – 299.

61. McGeer P.L., Kawamala Т., Walker D.G. et al. Glia 1993; 7: 84 – 92.

62. Giulian D., Corpuz M., Chapman S. et al. J Neurosci Res 1993; 36: 681 – 693.

63. Morioka Т., Kalehua A.N., Streit W.J. J Comp Neurol 1993; 327: 123 – 132.

64. Боголепов Н.Н., Бурд Г.С. Материалы VII Всесоюзного съезда невропатологов и психиатров. - М., 1981; 2: 32 – 35.

65. Бурд Г.С. Дыхательная недостаточность у больных с острыми нарушениями мозгового кровообращения: Дисс. д-ра мед. наук. - М., 1983.

66. Garcia J.H., Liu K.F., Ho K.L. Stroke 1995; 26: 636 – 642.

67. Charriaut-Marlangue C., Margaill I., Plotkine M., Ben-Ari Y. J Cereb Blood Flow Metab 1995; 15: 385 – 388.

68. Charriaut-Marlangue C., Margaill I., Represa A. J Cereb Blood Flow Metab 1996; 16: 186 – 194.

69. Li Y., Chopp M., Jiang N. et al. J Cereb Blood Flow Metab 1995; 15: 389 – 397.

70. Linnik M.D., Zobrist R.H., Hatfield M.D. Stroke 1993; 24: 2002 – 2008.

71. Sadoul R., Dubois-Dauphin M., Fernandel P.A. et al. Adv Neurol 1996; 71: 419 – 424.

72. Chopp M., Li Y. Acta Neurochir 1996; 66: 21 – 26.

73. Garcia J.H., Liu K.F., Yoshida Y. Et al. Am J Pathol 1994; 145: 728 – 740.

74. Zhang F., White J.G., Iadecola C. J Cereb Blood Flow Metab 1994; 14: 217 – 226.

75. Zhang R.L., Chopp M., Chen H. et al. J Neural Sci 1994; 125: 3 – 10.

76. http://humbio.ru/humbio/ishemia/00068913.htm

77. Iadecola C. Mechanisms of cerebral Ischemic damage. In: Cerebral Ischemia (Wolfgang Walz ed.). New Jersey, Totowa, Humana Press 1999; 3 – 33.

78. Krupinski J., Kaluza J., Kumar P. et al. Lancet 1993; 342: 742.

79. Krupinski J., Kaluza J., Kumar P. et al. .KrupinskiJ., Kaluza J., Kumar P. et al. Stroke 1994; 25: 1794 – 1798.

80. Липская Л.А. Цитология 1994; 36 (3): 303 – 309.

81. Bennett M.R., Huxlin K.R. Gen Pharmacol 1996; 27: 407 – 419.

82. Morley P., Tauskela J.S., Hakim A.M. Cerebral Ischemia (Wolfgang Walz ed.). New Jersey, Totowa, Humana Press 1999; 69 – 105.

83. Nicotera P., Zhivotovsky B., Orrenius S. Cell Calcium 1994; 16: 279 – 288.

84. Siesjo B.-K. Eur Neurol 1986; 25 (1): 45 – 56.

85. Choi D.W. J Neurosci 1990; 10: 2493 – 2501.

86. Hansen A.J. Physiol Rev 1985; 65: 101 – 148.

87. Fujisawa F.F., Dawson D., Browne S.E. at al. Brain Res 1993; 629: 73 – 78.

88. Lazarewitcz J.W. Acta Neurobiol Exp (Warsz) 1996; 56 (1): 299 – 311.

89. Morley P., Hogan M.J., Hakim A.M. Brain Pathol 1994; 4: 37 – 47.

90. Schousboe A., Frandsen A., Wayl P. et al. Neurotoxicology 1994; 15: 477 – 481.

91. Carmell J., Curtis A.R., Kemp J.A. et al. Neurosci Lett 1993; 153: 107 – 110.

92. Littman L., Glati B.S., Robinson M.B. Neurochem 1993; 61: 586 – 593.

93. Schoepp D.D., Conn P.J. Trends Pharmacol Sci 1993; 14: 13 – 20.

94. Sheardown M.J., Suzdak P.D., Nordholm E. Eur J Pharmacol 1993; 236: 347 – 353.

95. Scheinberg P. Neurology 1991; 41: 1867 – 1873.

96. Mitani A., Yanase H., Sakai K. Et al. Brain Res 1993; 601: 103 – 110.

97. Siesjo B.-K., Bengrsson F. J Cereb Blood Flow Metab 1989; 9: 127 – 140.

98. Berridge M.J. Triangi 1985; 3 (4): 79 – 90.

99. Orrenius S., McCabe M.S., Nicotera P. Toxicol Lett 1992; 64: 357 – 364.

100. Abe K., Kogure K., Yamamoto H. et al. J Neurochem 1987; 48: 503 – 509.

101. Завалишин И.А., Захарова М.Н. Журнал «Невропатология и психиатрия» 1996; 2: 111 – 114.

102. Суслина З.А. Ишемические нарушения мозгового кровообращения и система простаноидов (клинико-биохимические исследования): Дисс. д.м.н. – М., 1991; 331.

103. Packer L.L., Packer L., Prilipko Y., Cyirsten Y. Free radicals in the brain. Berlin 1992; 1 – 20.

104. Choi D.W. Proc nati Acad Sci USA 1993; 90: 9741.

105. Steng M., Greenberg M.E. 1990. The regulation and function of c-fos and other immediate early genes in the nervous system // Neuron. 4: 477–85.

106. Koistinaho J., Hökfelt T. 1997. Altered gene expression in brain ischemia // Neuroreport. V.8(2):1–8.

107. Honkaniemi J., Sharp F.R. 1996. Global ischemia induces immediate-early genes encoding zinc finger transcription factors // J Cereb Blood Flow Metab. V.16(4):557–565.

108. Akins P.T., Liu P.H., Hsu C.Y. 1996. Immediate early gene expression in response to cerebral ischemia. Friend or foe?// Stroke. V.27(9) :1682–1687.

109. Kinouchi H., Sharp F.R., Chan P.H., Koistinaho J., Sagar S.M., Yoshimoto T. 1994. Induction of c-fos, junB, c-jun, and hsp70 mRNA in cortex, thalamus, basal ganglia, and hippocampus following middle cerebral artery occlusion // J Cereb Blood Flow Metab. V.14(5).

110. Bergeron M., Yu A.Y., Solway K.E., Semenza G.L., Sharp F.R. 1999. Induction of hypoxia-inducible factor-1 (HIF-1) and its target genes following focal ischaemiain rat brain// Eur J Neurosci. (12):4159-70.

111. Bergeron M., Gidday J.M., Yu A.Y., Semenza G.L, Ferriero D.M., Sharp F.R. 2000. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain// Ann Neurol. 48(3):285-96.

112. Crosby M.E., Kulshreshtha R., Ivan M., Glazer P.M. 2009. MicroRNA regulation of DNA repair gene expression in hypoxic stress // Cancer Res. 69(3):1221-9. Erratum in: Cancer Res. 69(7):3240.

113. Xia X., Lemieux M.E., Li W., Carroll J.S., Brown M., Liu X.S., Kung A.L. 2009. Integrative analysis of HIF binding and transactivation reveals its role in maintaininghistone methylation homeostasis // Proc Natl Acad Sci USA. 106(11):4260-5.

114. Benjamin I.J., Horie S., Greenberg M.L., Alpern R.J., Williams R.S. 1992. Induction of stress proteins in cultured myogenic cells. Molecular signals for the activation of heat shock transcription factor during ischemia// The journal of clinical investigation. V.89(5):1685–1689.

115. Obrenovitch T.P. 2008. Molecular physiology of preconditioning-induced brain tolerance to ischemia // Physiol Rev. (1): 211-47.

116. Iadecola C., Zhang F., Xu X. 1995. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage // Am J Physiol. V.268(2): 286–292.

117. Iadecola C. 1999. Mechanisms of cerebral ischemic damage. in Cerebral ischemia by Walz W. // Humana Press Totowa, New Jersey.

118. Moskowitz M.A., Lo E.H., Iadecola C. 2010. The science of stroke: mechanisms in search of treatments // Neuron. 67(2):181-98. Erratum in: Neuron. 2010 Oct 6;68(1):161.

119. Pabst S., Hazzard J.W., Antonin W., Südhof T.C., Jahn R., Rizo J., Fasshauer D. 2000. Selective interaction of complexin with the neuronal SNARE complex. Determinationof the binding regions // J Biol Chem. Jun 275(26):19808–19818.

120. Südhof T.C, Rothman J.E. 2009. Membrane fusion: grappling with SNARE and SM proteins // Science. 323(5913): 474–477.

121. Ishizuka T., Saisu H., Odani S., Abe T. 1995. Synaphin: a protein associated with the docking/fusion complex in presynaptic terminals // Biochem Biophys Res Commun 213 (3): 1107–1114.

122. Weninger K.R. 2011. Complexin arrests a neighbor // Nat Struct Mol Biol. 18(8):861–863.

123. Jorquera R.A., Huntwork-Rodriguez S., Akbergenova Y., Cho R.W., Littleton J.T. 2012. Complexin controls spontaneous and evoked neurotransmitter release by regulating and timing and properties of synaptotagmin activity // Journal of Neuroscience 32 (50): 18234–18245.

124. Hobson R.J., Liu Q., Watanabe S., Jorgensen E.M. 2011. Complexin maintains vesicles in the primed state in C. Elegans // Current Biology; 21 (2): 106–113.

125. Maximov A., Tang J., Yang X., Pang Z.P., Sudhof T.C. 2009. Complexin controls the force transfer from SNARE complexes to membranes in fusion // Science; 323 (5913): 516–521.

126. Raevskaya N.M., Dergunova L.V., Vladychenskaya I.P., Stavchansky V.V., Oborina M.V., Poltaraus A.B., Limborska S.A. 2005. Structural organization of the human complexin 2 gene(CPLX2) and aspects of its functional activity // Gene. 359:127–137.

127. An S.J., Grabner C.P., Zenisek D. 2010. Real-time visualization of complexin during single exocytic events// Nat Neurosci. V.13(5):577–83.

128. Hazell A.S., Wang D. 2011. Identification of complexin II in astrocytes: a possible regulator of glutamate release in these cells // Biochem Biophys Res Commun. 404(1):228–32

129. Hazell A.S. 2007. Excitotoxic mechanisms in stroke: an update of concepts andtreatment strategies. // Neurochem Int. 50(7–8):941–53.

130. Farooqui A.A., Ong W.Y., Horrocks L.A. 2008. Neurochemical Aspects of Excitotoxicity // Springer, New York, NY, USA, p168.

131. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. - М.: Медицина, 2001. - 328 с.

132. Ashmarin I.P., Nezavibat'ko V.N., Levitskaya N.G., Kamensky A.A. 1995. Desing and investigation of ACTH(4-10) analog deprived of D-aminoacids and hydrophobic radicals// Neurosci. Res. Commun. V.16:105–112.

133. Гусев Е.И., Скворцова В.И., Чуканова Е.И. Семакс в профилактике прогрессирования и развития обострений у больных с дисциркуляторной энцефалопатией//Журнал неврологии и психиатрии им. С.С. Корсакова. 2005, № 2.

134. Ашмарин И.П., Незавибатьков Н.Н., Мясоедов Н.Ф., Каменский А.А. и др. Ноотропный аналог адренокортикотропина 4-10 — Семакс (15-летний опыт разработки и изучения) //Журнал высшей нервной деятельности. 1997, т.47, с.419-425.

135. Hershkowitz M., Zwiers H., Gispen W.H. The effect of ACTH on rat brain

Synaptic plasma membrane lipid fluidity. Biochem Biophys Acta. 1982 Nov. 22; 692 (3): 495 – 497.

136. Potaman V.N., Alfeeva L.Y., Kamensky A.A., Nezavibatko V.N. Degradation of ACTH/MSH (4 – 10) and its synthetic analog semax by rat serum enzymes: an inhibitor study. Peptides. 1993. V. 14. №3. p. 491 – 495.

137. Ашмарин И.П., Каразеева Е.П., Ляпина Л.А., Самонина Г.Е. Регуляторная активность простейших пролинсодержащих пептидов PG, GP, PGP и GPGG и возможные источники их биосинтеза // Биохимия, 1998. т.63, вып.2, стр. 149 – 155.

138. Grivennikov I.A., Dolotov O.V., Gol'dina Iu.I. 1999. Peptide factors in processes of proliferation, differentiation, and extended viability of mammalian nervous system cells // Mol Biol (Mosk). V.33(1):120-126.

139. Асташкин Е.И., Беспалова Ю.Б., Гривенников И.А., Смирнов О.Н., Глезер М.Г., Мясоедов Н.Ф. 2000. Изучение влияния семакса на Са2+-ответы нейтрофилов человека // Доклады академии наук. 374(3):401–403.

140. Bashkatova V.G., Koshelev V.B., Fadyukova O.E., Alexeev A.A., Vanin A.F., Rayevsky K.S., Ashmarin I.P., Armstrong D.M. 2001. Novel synthetic analogue of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia// Brain. Res. 894:145–149.

141. Povarova O.V., Garibova T.L., Kalenikova E.I., Galaeva I.P., Kraineva V.A., Medvedev O.S., Voronina T.A. Effect of phenyl-tert-butylnitrone, mexidol and nooglutil on the ischemic lesion zone and memory in rats following middle cerebral artery occlusion // Eksp Klin Farmakol. 2004. V. 67(1). P. 3 – 6.

142. Hugget J., Dheda K., Bustin S., Zumla A. Real-time RT-PCR normalisation; strategies and considerations // Genes Immun. 2005. V. 6(4). P. 279 – 284.

143. Bustin S. Absolute quantification of mRNA using real-time-reverse-transcription polymerase chain reaction assays. Journal of molecular endocrinology. 2000 V.25. P. 169 – 193.

144. Bustin S., Nolan T. Pitfalls of quantitative Real-Time-Reverse-transcription polymerase chain reaction. Journal of biomolecular techniques. 2004 V. 15. P. 155 – 166.

145. Pffafl M.W. A new mathematical model for relative quantitation in real-time RT-PCR. Nucleic Acids Research. 2001. V.29. N.9 P. 2002 – 2007.

146. Pffafl M., Horgan G., Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression result in real-time PCR. Nucleic Acids Research. 2002. V.30 N.9 P. 1 – 10.

147. Garcia J.H., Yoshida Y., Chen H., Li Y., Zhang Z.G., Lian J., Chen S., Chopp M. Progression from ishemic injury to infarct following middle cerebral arteryocclusion in the rat // Am J. Pathol. 1993. V. 142(2). P. 623 – 635.

148. Wishcamper C.A., Brooks D.M., Coffin J.D., Lurie D.I. Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mic e// Brain Research. 2003. V. 974 P. 88 – 98.

149. Дмитриева В.Г., Дергунова Л.В., Поварова О.В., Скворцова В.И., Лимборская С.А., Мясоедов Н.Ф. 2008. Действие семакса и его С-концевого трипептида PGP на экспрессию генов факторов роста и их рецепторов в условиях экспериментальной ишемии мозга крыс // Доклады академии наук. Т.422(2):258–261.

150. Stavchansky V.V., Yuzhakov V.V., Botsina A.Y., Skvortsova V.I., Bondurko L.N., Tsyganova M.G., Limborska S.A., Myasoedov N.F., Dergunova L.V. 2011. The еffect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study // J Mol Neurosci 45:177–185

64